Table 2 -.

Prevalence ratios (PRs) of HIV by breast cancer stage, grade, metastatic disease status, and IHC subtype.

	Unadjusted PR	p-value	Adjusted PR*	p-value
Stage at Diagnosis
Early Stage	1 (Ref)		1 (Ref)
Late Stage	1.36 (1.07–1.73)	0.01	1.12 (0.90–1.39)	0.31
Metastatic disease
No metastasis	1 (Ref)		1 (Ref)
At least 1 known site of metastasis	1.14 (0.85 – 1.54)	0.38	1.26 (0.96 – 1.65)	0.10
Tumour grade at diagnosis
1	1 (Ref)		1 (Ref)
2	1.21 (0.70 – 2.11)	0.49	1.27 (0.79 – 2.04)	0.33
3	1.01 (0.58 – 1.78)	0.96	1.00 (0.61 – 1.63)	0.99
IHC4 subtypes at diagnosis
Luminal A	1 (Ref)		1 (Ref)
Luminal B	1.26 (0.85 – 1.88)	0.26	0.88 (0.61 – 1.27)	0.49
Her2-positive	1.31 (0.72 – 2.40)	0.38	1.00 (0.58 – 1.70)	0.99
Triple Negative	1.44 (0.91 – 2.29)	0.12	1.10 (0.73 – 1.66)	0.64
Luminal B (ER+/PR+; Her2-; Ki67≥14%)	1 (Ref)		1 (Ref)
Luminal B (ER+/PR+; Her2+)	1.40 (1.04 – 1.88)	0.03	1.19 (0.91 – 1.57)	0.21

^*Adjusted for age (linear) and ethnicity (black vs non-black)